Please ensure Javascript is enabled for purposes of website accessibility

Why FIGS Stock Soared Today

By Jeremy Bowman - Jun 21, 2021 at 6:54PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares of the recent IPO jumped on bullish analyst coverage.

What happened

Shares of FIGS (FIGS 0.78%) jumped 17.1% today after the maker of medical scrubs received a slew of positive analyst notes.

The good news came as the quiet period for analyst coverage lapsed following the company's IPO in May.

A woman in medical scrubs in a professional setting.

Image source: Getty Images.

So what

At least seven analysts gave FIGS positive ratings this morning, calling the stock a buy or rating it an outperform. Among the analysts weighing in was Piper Sandler's Erinn Murphy who gave the stock an overweight rating and a price target of $44, just slightly above the $42.61 it closed at today. Murphy said FIGS is "uniquely positioned as a growth brand" and is disrupting the $79 billion medical apparel industry.

Cowen's John Kernan called the stock an outperform and said the company's guidance was conservative. Kernan predicted that the company would triple revenue to $1.1 billion by 2025, and its market cap would exceed $8 billion. FIGS closed the day with a market cap of $6.8 billion.

Now what

FIGS has now nearly doubled from its $22 IPO price after the company debuted on May 27. The company offers an interesting opportunity in a corner of the apparel market that's rarely considered. FIGS' revenue growth has been impressive, accelerating during the pandemic last year to rise 138% to $263.1 million, following 102% revenue growth in 2019. However, it won't be easy to sustain a triple-digit revenue growth rate in the apparel industry as the sector doesn't have the same scalability of, say, the tech sector.

Even the forecasts of the most bullish analysts indicate that the stock may be ready to take a breather after nearly doubling in less than a month.


Jeremy Bowman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

FIGS, Inc. Stock Quote
FIGS, Inc.
$12.85 (0.78%) $0.10
Piper Sandler Companies Stock Quote
Piper Sandler Companies
$132.94 (0.80%) $1.06
Cowen Inc. Stock Quote
Cowen Inc.
$38.72 (0.05%) $0.02

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/16/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.